Haley Patrick J.

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return1%1%1%1%0%
Sale Success Rate2 of 292 of 291 of 291 of 290 of 29

Exelixis, Inc.

Drugs » Biotechnology

EVP, Commercial:

Holdings: 322.85K shares

Sentiment

Insider Trading Sentiment: Reduce

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--